Vaccines, blood, antisera, toxins and cultures in   Austria

Exports In 2023, Austria exported $8.02B in Vaccines, blood, antisera, toxins and cultures, making it the 11th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most exported product in Austria. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Austria are: United States ($2.47B), Germany ($1.84B), Italy ($464M), France ($329M), and China ($292M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Austria between 2022 and 2023 were Germany ($464M), United States ($270M), and China ($131M).

Imports In 2023, Austria imported $6.32B in Vaccines, blood, antisera, toxins and cultures, becoming the 13th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most imported product in Austria. Austria imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($2.33B), Germany ($1.13B), Italy ($536M), Switzerland ($508M), and France ($386M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Austria between 2022 and 2023 were United States ($727M), Germany ($337M), and Italy ($120M).